Guggenheim Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-110,380	Closed	-$240K	–	1798
2025 Q3	$240K	Sell	110,380 -12,487	-10%	-$29.5K	﹤0.01%	1467
2025 Q2	$211K	Sell	122,867 -25,483	-17%	-$63.4K	﹤0.01%	1495
2025 Q1	$494K	Buy	148,350 +49,410	+50%	+$255K	﹤0.01%	1208
2024 Q4	$732K	Sell	98,940 -10,880	-10%	-$101K	0.01%	1074
2024 Q3	$1.03M	Sell	109,820 -2,651	-2%	-$25.1K	0.01%	1087
2024 Q2	$902K	Buy	112,471 +35,008	+45%	+$375K	0.01%	1177
2024 Q1	$1.15M	Sell	77,463 -31,638	-29%	-$368K	0.01%	1121
2023 Q4	$887K	Buy	+109,101	New	+$571K	0.01%	1212
2023 Q1	–	Sell	-111,286	Closed	-$711K	–	1963
2022 Q4	$711K	Sell	111,286 -564	-0.5%	-$4.4K	0.01%	1331
2022 Q3	$1.07M	Sell	111,850 -16,701	-13%	-$193K	0.01%	1112
2022 Q2	$1.42M	Buy	128,551 +15,438	+14%	+$202K	0.01%	1059
2022 Q1	$1.88M	Buy	113,113 +8,517	+8%	+$132K	0.01%	1052
2021 Q4	$2M	Buy	104,596 +9,297	+10%	+$205K	0.01%	1057
2021 Q3	$2.35M	Sell	95,299 -2,761	-3%	-$65.1K	0.01%	976
2021 Q2	$2.55M	Buy	98,060 +8,638	+10%	+$225K	0.02%	959
2021 Q1	$2.83M	Buy	89,422 +20,024	+29%	+$830K	0.02%	856
2020 Q4	$3.22M	Sell	69,398 -13,243	-16%	-$526K	0.02%	764
2020 Q3	$2.72M	Sell	82,641 -29,961	-27%	-$919K	0.02%	762
2020 Q2	$3.09M	Buy	+112,602	New	+$3.7M	0.02%	707